ArticleCancer management and research2025

Tumor-Associated Autoantibodies Anti-p53 is Associated with Poor Prognosis in Patients with Lung Adenocarcinoma.

Keying Jing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.